Literature DB >> 11895465

The effect of the Interleukin-6-174G > C promoter gene polymorphism on endothelial function in healthy volunteers.

D J Brull1, C P M Leeson, H E Montgomery, M Mullen, M deDivitiis, S E Humphries, J E Deanfield, C P M Lesson.   

Abstract

AIMS: Atherosclerosis is a chronic inflammatory condition, manifest in its early stages by endothelial dysfunction. Interleukin-6 (IL6) plays a key role in driving this process through stimulation of acute phase protein synthesis. We have examined the effect of the IL6 gene -174G > C promoter polymorphism on endothelial function in a group of healthy subjects.
METHODS: 248 adults aged 20-28 years participated. Polymerase chain reaction was performed for the -174G > C polymorphism. Brachial artery diameter was measured at rest and after forearm cuff occlusion by high-resolution ultrasound. Responses were represented as absolute flow mediated dilatation (FMDA).
RESULTS: Overall there was a trend towards greater FMDA for genotype CC, P = 0.14. No effect was seen in women; however, in men, following multivariate analysis, there was a significant association between genotype and FMDA, P = 0.04. In addition, a significant detrimental effect of smoking on FMDA was only seen in males of genotype CC (P < 0.05) when compared to nonsmokers of the same genotype.
CONCLUSION: IL6-174G > C promoter polymorphism influences endothelial function in healthy male subjects. The detrimental effect of smoking on endothelial function is most clearly seen in men of genotype -174 CC, suggesting a genotype-specific interaction with smoking.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11895465     DOI: 10.1046/j.1365-2362.2002.00966.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  7 in total

1.  The interleukin-6 promoter polymorphism is associated with elevated leukocyte, lymphocyte, and monocyte counts and reduced physical fitness in young healthy smokers.

Authors:  J R Ortlepp; J Metrikat; K Vesper; V Mevissen; F Schmitz; M Albrecht; P Maya-Pelzer; P Hanrath; C Weber; K Zerres; R Hoffmann
Journal:  J Mol Med (Berl)       Date:  2003-08-20       Impact factor: 4.599

2.  Hypomethylation of interleukin-6 (IL-6) gene increases the risk of essential hypertension: a matched case-control study.

Authors:  S-Q Mao; J-H Sun; T-L Gu; F-B Zhu; F-Y Yin; L-N Zhang
Journal:  J Hum Hypertens       Date:  2017-03-16       Impact factor: 3.012

3.  Association Between Lipids and Arterial Stiffness for Primary Cardiovascular Prevention in a General Middle-Aged European Population.

Authors:  Alexandre Vallée
Journal:  Front Cardiovasc Med       Date:  2022-05-27

4.  Interleukin-6 -634 C/G and -174 G/C polymorphisms in Korean patients undergoing hemodialysis.

Authors:  Jung-Hwa Ryu; Seung-Jung Kim
Journal:  Korean J Intern Med       Date:  2012-09-01       Impact factor: 2.884

Review 5.  Common genetic factors for depression and cardiovascular disease.

Authors:  Brigitta Bondy
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

6.  Association between serum uric acid and arterial stiffness in a large-aged 40-70 years old population.

Authors:  Alexandre Vallée
Journal:  J Clin Hypertens (Greenwich)       Date:  2022-06-24       Impact factor: 2.885

7.  Association of a common TLR-6 polymorphism with coronary artery disease - implications for healthy ageing?

Authors:  Lutz Hamann; Alexander Koch; Saubashya Sur; Nadja Hoefer; Christiane Glaeser; Susanne Schulz; Michael Gross; Andre Franke; Ute Nöthlings; Kai Zacharowski; Ralf R Schumann
Journal:  Immun Ageing       Date:  2013-10-30       Impact factor: 6.400

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.